Promising Vaccine Promises Longer-Lasting Covid Immunity
Credit Centers for Disease Control and Prevention (CDC) via UnsplashA scientific team from the Yong Loo Lin School of Medicine at the National
Stay updated with breaking news from Molecular Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Credit Centers for Disease Control and Prevention (CDC) via UnsplashA scientific team from the Yong Loo Lin School of Medicine at the National
A scientific team from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and Monash University has engineered
Researchers have developed a new strain of vaccinia virus, which can replicate in tumor cells while maintaining increased immunogenicity. Specifically, it can to induce so-called immunogenic cell death in tumor cells.
Vaccinia viruses are therapeutic tools with different biomedical applications depending on the susceptibility characteristics. For example, the strain called MVA (modified vaccinia Ankara), which is unable to replicate in mammalian cells, triggers a potent immune system response and is used to develop vaccines against COVID-19 or AIDS.
Researchers have found that a newly developed modified sugar increases the efficacy and safety of antisense oligonucleotides designed to treat central nervous system disease.